Assessment of the role of the Xpert Bladder Cancer detect assay in patients with asymptomatic hematuria

• Conditions: R31; D41.4; C67; Unspecified haematuria; Bladder; Malignant neoplasm of bladder

• Registration Number: DRKS00027469
• Lead Sponsor: Cepheid Europe SAS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-21
• Study Completion: 2022-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

hematuria

Exclusion Criteria

known bladder tumor

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Exclusion / evidence of a bladder tumor

Secondary Outcome Measures

Name	Time	Method
Predictive value of tumor markers